MATUCCI CERINIC, MARCO
 Distribuzione geografica
Continente #
AS - Asia 1.963
EU - Europa 1.051
NA - Nord America 411
OC - Oceania 8
SA - Sud America 4
AF - Africa 1
Totale 3.438
Nazione #
CN - Cina 903
SG - Singapore 603
RU - Federazione Russa 476
HK - Hong Kong 422
US - Stati Uniti d'America 391
IT - Italia 311
SE - Svezia 78
NL - Olanda 52
DE - Germania 31
FI - Finlandia 28
GB - Regno Unito 27
CA - Canada 18
FR - Francia 18
IN - India 11
TR - Turchia 8
NZ - Nuova Zelanda 5
TW - Taiwan 5
UA - Ucraina 5
AT - Austria 4
ES - Italia 4
JP - Giappone 4
PE - Perù 4
PT - Portogallo 4
AU - Australia 3
BE - Belgio 3
HU - Ungheria 3
SA - Arabia Saudita 3
CH - Svizzera 2
LT - Lituania 2
MX - Messico 2
GR - Grecia 1
IL - Israele 1
KR - Corea 1
KZ - Kazakistan 1
MA - Marocco 1
PH - Filippine 1
PL - Polonia 1
RO - Romania 1
Totale 3.438
Città #
Shanghai 597
Hong Kong 421
Singapore 370
Moscow 149
Dallas 77
Boardman 44
Milan 44
Rome 35
Amsterdam 29
New York 28
Guangzhou 25
Ashburn 21
Clifton 19
Bologna 18
Santa Clara 18
Shenzhen 18
Helsinki 17
Lawrence 17
Princeton 17
Florence 15
Beijing 14
Lappeenranta 10
Munich 10
Turin 9
Forlì 8
Jiaxing 8
London 8
Los Angeles 8
Hangzhou 7
Vancouver 7
Foshan 6
Palermo 6
Toronto 6
Wuxi 6
Cormons 5
Council Bluffs 5
Hyderabad 5
Nuremberg 5
Xi'an 5
Ancona 4
Istanbul 4
Lima 4
Paris 4
St Petersburg 4
Amadora 3
Anshan 3
Blackburn 3
Brussels 3
Ede 3
Frankfurt am Main 3
Giulianova 3
Izmir 3
Kassel 3
Naples 3
New Taipei City 3
Osimo 3
Ottawa 3
Padova 3
Palmerston North 3
Pietramelara 3
Riyadh 3
Seattle 3
Southam 3
Spijkenisse 3
Vaprio d'Adda 3
Washington 3
Angers 2
Angier 2
Aobadai 2
Auckland 2
Battipaglia 2
Bitonto 2
Busto Arsizio 2
Dalian 2
Enschede 2
Galliate 2
Genoa 2
Glasgow 2
Hyde Park 2
Iztapalapa 2
L’Aquila 2
Madrid 2
Mantova 2
Marana 2
Melbourne 2
Modena 2
Modigliana 2
Monte San Savino 2
New Delhi 2
Nizhniy Novgorod 2
Nocera Umbra 2
Osaka 2
Pamplona 2
Pontedera 2
Pune 2
Pécs 2
Quanzhou 2
Rui'an 2
San Francisco 2
San Jose 2
Totale 2.271
Nome #
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 71
The Italian version of the Hand Mobility in Scleroderma (HAMIS) test: evidence for its validity and reliability 37
ENDOMETRIOSI E MALATTIE REUMATICHE: LA PUNTA DELL’ICEBERG DEI NUMEROSI DISTURBI MESTRUALI IN CORSO DI MALATTIA REUMATICA 35
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation 33
Riabilitazione dell’articolazione temporomandibolare (atm) in pazienti con sclerosi sistemica (ssc): confronto tra due protocolli. Risultati preliminari 31
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 30
Very early and early diagnosis of systemic sclerosis 28
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 28
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 27
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 27
"Atlas of Capilaroscopy in Rheumatic Diseases" - Chapter: The microcirculation and Rheumatic Diseases 26
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 25
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 24
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 23
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 23
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 23
Systemic Sclerosis Association with Malignancy 22
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database 21
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 20
Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging 20
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study 20
"Autoimmunity" - Chapter: Autoantibodies in systemic sclerosis 20
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 20
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 20
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience 20
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 20
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 19
Shoulder impingement syndrome in water polo players: muscle shortening manoeuvre controls pain intensity, recovers function and normalizes sonographic parameters 19
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 19
The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress 19
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition 18
Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis 17
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 17
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort 17
ASSESSMENT OF HEALTH LITERACY IN A COHORT OF SYSTEMIC SCLEROSIS (SSC) PATIENTS 17
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 17
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 17
Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review 17
Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients 17
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study 17
Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis 17
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 17
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 16
Performance of ultra-high-frequency ultrasound in the evaluation of skin involvement in systemic sclerosis: A preliminary report 16
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 16
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 16
LA PROSPETTIVA DEI PAZIENTI REUMATICI SULL’UTILITÀ DELLA TELEMEDICINA PER IL FOLLOW UP DELLA MALATTIA: ESPERIENZE E PROBLEMATICHE ORGANIZZATIVE DURANTE LA PANDEMIA 16
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 16
Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement 16
The multifaceted problem of pulmonary arterial hypertension in systemic sclerosis 16
Stressful life events at the onset and during the evolution of systemic sclerosis 16
A genetic variant located in the promoter of the uPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 15
Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review 15
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases 15
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 15
Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis–Interstitial Lung Disease: A Systematic Review 15
Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today 15
Alfabetizzazione sanitaria e pazienti affetti da Sclerosi Sistemica 15
[Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs] 15
Treatment For Metatharsalgia By Plantar Insoles And Silicone Orthosis For Toes In Patients With Rheumatoid Arthritis And Osteoarthritis: A Cross-Over Study 15
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 15
Improvements of vascular outcomes in systemic sclerosis: halfway through, but still far to go 15
Early diagnosis of systemic sclerosis, where do we stand today? 14
Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis 14
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population 14
A custom-made splint is useful in the treatment of Osteoarthritis of the trapeziometacarpal joint 14
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity 14
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 14
Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association? 14
Clinical and demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA) 14
Very early systemic sclerosis 14
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 13
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 13
A combined rehabilitative program is efficacious in the treatment of hands of Systemic Sclerosis patients 13
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 13
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 13
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 13
Il linfodrenaggio manuale migliora l'edema agli arti superiori e la funzionalità delle mani nei pazienti con Sclerosi Sistemica (SSc) in fase edematosa 12
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management 12
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort 12
The combination of connective tissue massage, Kabat's technique, kinesitherapy and home exercise is helpful in face rehabilitation of Systemic Sclerosis patients 12
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 12
GASTROINTESTINAL INVOLVEMENT AND QUALITY OF LIFE IN A COHORT OF SYSTEMIC SCLEROSIS (SSC) PATIENTS 12
Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis 12
The target on B cells in Systemic Sclerosis: a “midsummer dream” to extinguish inflammation and prevent early disease progression to fibrosis 12
Impairment in the telocyte/CD34+ stromal cell network in human rheumatoid arthritis synovium 11
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative 11
In search for the ideal anatomical composition of vascularised human skin equivalents for systemic sclerosis translational research: should we recruit the telocytes? 11
MENSTRUATION-RELATED DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS): BLEEDING AND PAIN 11
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 11
One year later: The case of tocilizumab in COVID-19 11
AB1540-HPR NURSING INTERVENTIONS FOR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDS) PATIENTS ON BIOLOGIC THERAPY: A SYSTEMATIC LITERATURE REVIEW (SLR) 11
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 11
Systemic Sclerosis Patients Experiencing Mindfulness-Based Stress Reduction Program: The Beneficial Effect on Their Psychological Status and Quality of Life 11
A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia 11
A contribution to the debate about the possible different clinical severity between hemophilia A and B 11
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 11
Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 11
Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review 11
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 11
Totale 1.749
Categoria #
all - tutte 63.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 3 0 0 0 0 0
2021/202238 0 0 11 3 1 3 1 0 0 16 1 2
2022/2023170 42 28 9 1 3 16 29 20 15 0 6 1
2023/20241.249 4 9 14 20 18 574 222 176 10 26 48 128
2024/20252.822 986 202 92 159 357 567 459 0 0 0 0 0
Totale 4.284